Pill vs. needle: new hope for patchy baldness?
NCT ID NCT07174011
First seen Oct 31, 2025 · Last updated Apr 28, 2026 · Updated 19 times
Summary
This study tested an oral medication called roflumilast against steroid injections for people with mild to moderate patchy alopecia areata. Fifty adults took part to see which treatment better helps hair regrow over 16 weeks. The goal is to find a simpler, pill-based option for this autoimmune hair loss condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cairo University
Giza, Cairo Governorate, 13114, Egypt
Conditions
Explore the condition pages connected to this study.